Concepedia

Annemarie Hekman

AH

Statistics

Publications

3

Citations

91

H-Index

3

Active since

1992

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Annemarie Hekman is an author at The Netherlands Cancer Institute specializing in immunotherapy, continuous infusion pharmacology, and cancer immunology.

Publications per year

1992–1995

3

Publications

3

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects

L.T. Vlasveld, EM Rankin, Annemarie Hekman et al. · British Journal of Cancer · 1992 · 43 citations · Full text

, , +17

Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19

L. Tom Vlasveld, Annemarie Hekman, Florry A. Vyth‐Dreese et al. · Cancer Immunology Immunotherapy · 1995 · 33 citations · Full text

, , +14

Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon α

Wim M.J. Vuist, Marjan J.W. Visseren, Myrthe Otsen et al. · Cancer Immunology Immunotherapy · 1993 · 15 citations · Full text

, , +12

1–3 of 3